Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD27 expression on human peripheral blood lymphocytes - Staining comparisons between BD Horizon™ BB515- and FITC-conjugated antibodies. Human whole blood was stained with either BD Horizon BB515 Mouse IgG1, κ Isotype Control (Cat. No. 564416; dashed line histogram) or BD Horizon BB515 Mouse Anti-Human CD27 antibody (Cat. No. 564642/564643; bold solid line histogram). Alternatively, cells were stained with FITC Anti-Human CD27 antibody (Cat. No. 555440/557329/560986; thin solid line histogram). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Overlaid histograms are shown to facilitate staining comparisons between: BB515 Anti-CD27 antibody versus its Ig Isotype Control (Left Panel), and BB515 Anti-CD27 antibody versus FITC Anti-CD27 antibody (Right Panel). The fluorescence histograms showing CD27 expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD27 expression on human peripheral blood lymphocytes - Staining comparisons between BD Horizon™ BB515- and FITC-conjugated antibodies. Human whole blood was stained with either BD Horizon BB515 Mouse IgG1, κ Isotype Control (Cat. No. 564416; dashed line histogram) or BD Horizon BB515 Mouse Anti-Human CD27 antibody (Cat. No. 564642/564643; bold solid line histogram). Alternatively, cells were stained with FITC Anti-Human CD27 antibody (Cat. No. 555440/557329/560986; thin solid line histogram). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Overlaid histograms are shown to facilitate staining comparisons between: BB515 Anti-CD27 antibody versus its Ig Isotype Control (Left Panel), and BB515 Anti-CD27 antibody versus FITC Anti-CD27 antibody (Right Panel). The fluorescence histograms showing CD27 expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD27 expression on human peripheral blood lymphocytes - Staining comparisons between BD Horizon™ BB515- and FITC-conjugated antibodies. Human whole blood was stained with either BD Horizon BB515 Mouse IgG1, κ Isotype Control (Cat. No. 564416; dashed line histogram) or BD Horizon BB515 Mouse Anti-Human CD27 antibody (Cat. No. 564642/564643; bold solid line histogram). Alternatively, cells were stained with FITC Anti-Human CD27 antibody (Cat. No. 555440/557329/560986; thin solid line histogram). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Overlaid histograms are shown to facilitate staining comparisons between: BB515 Anti-CD27 antibody versus its Ig Isotype Control (Left Panel), and BB515 Anti-CD27 antibody versus FITC Anti-CD27 antibody (Right Panel). The fluorescence histograms showing CD27 expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD27 expression on human peripheral blood lymphocytes - Staining comparisons between BD Horizon™ BB515- and FITC-conjugated antibodies. Human whole blood was stained with either BD Horizon BB515 Mouse IgG1, κ Isotype Control (Cat. No. 564416; dashed line histogram) or BD Horizon BB515 Mouse Anti-Human CD27 antibody (Cat. No. 564642/564643; bold solid line histogram). Alternatively, cells were stained with FITC Anti-Human CD27 antibody (Cat. No. 555440/557329/560986; thin solid line histogram). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Overlaid histograms are shown to facilitate staining comparisons between: BB515 Anti-CD27 antibody versus its Ig Isotype Control (Left Panel), and BB515 Anti-CD27 antibody versus FITC Anti-CD27 antibody (Right Panel). The fluorescence histograms showing CD27 expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD27 expression on human peripheral blood lymphocytes - Staining comparisons between BD Horizon™ BB515- and FITC-conjugated antibodies. Human whole blood was stained with either BD Horizon BB515 Mouse IgG1, κ Isotype Control (Cat. No. 564416; dashed line histogram) or BD Horizon BB515 Mouse Anti-Human CD27 antibody (Cat. No. 564642/564643; bold solid line histogram). Alternatively, cells were stained with FITC Anti-Human CD27 antibody (Cat. No. 555440/557329/560986; thin solid line histogram). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Overlaid histograms are shown to facilitate staining comparisons between: BB515 Anti-CD27 antibody versus its Ig Isotype Control (Left Panel), and BB515 Anti-CD27 antibody versus FITC Anti-CD27 antibody (Right Panel). The fluorescence histograms showing CD27 expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD27 expression on human peripheral blood lymphocytes - Staining comparisons between BD Horizon™ BB515- and FITC-conjugated antibodies. Human whole blood was stained with either BD Horizon BB515 Mouse IgG1, κ Isotype Control (Cat. No. 564416; dashed line histogram) or BD Horizon BB515 Mouse Anti-Human CD27 antibody (Cat. No. 564642/564643; bold solid line histogram). Alternatively, cells were stained with FITC Anti-Human CD27 antibody (Cat. No. 555440/557329/560986; thin solid line histogram). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Overlaid histograms are shown to facilitate staining comparisons between: BB515 Anti-CD27 antibody versus its Ig Isotype Control (Left Panel), and BB515 Anti-CD27 antibody versus FITC Anti-CD27 antibody (Right Panel). The fluorescence histograms showing CD27 expression (or Ig Isotype control staining) were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD™ CompBeads can be used as surrogates to assess fluorescence spillover (Compensation). When fluorochrome conjugated antibodies are bound to CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and CompBead to ensure that BD Comp beads are appropriate for your specific cellular application.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
For optimal results, it is recommended to perform 2 washes after staining with antibodies. Cells may be prepared, stained with antibodies and washed twice with wash buffer per established protocols for immunofluorescence staining, prior to acquisition on a flow cytometer. Performing fewer than the recommended wash steps may lead to increased spread of the negative population.
The M-T271 monoclonal antibody specifically binds to CD27. CD27 presents as a type I transmembrane, disulphide-linked 110 kDa homodimer comprised of two polypeptide chains. The CD27 molecule is a lymphocyte-specific member of the TNF/NGF-R family, and is expressed on a subset of human thymocytes and on the majority of mature T lymphocytes, activated B cells and NK cells. CD27 is highly induced on T cells after TCR stimulation. CD27 binds to CD70 (also known as, CD27 ligand or CD27L) and may be involved in cellular interaction of T and B lymphocytes.
The antibody was conjugated to BD Horizon BB515 which is part of the BD Horizon Brilliant™ Blue family of dyes. With an Ex Max near 490 nm and an Em Max near 515 nm, BD Horizon BB515 can be excited by the blue laser (488 nm) laser and detected with a 530/30 nm filter. This dye has been exclusively developed by BD Biosciences and is up to seven times brighter than FITC with less spillover into the PE channel. Due to similar excitation and emission properties, BB515, FITC, and Alexa Fluor® 488 cannot be used simultaneously. It is not recommended to use BB515 in cocktails that include Streptavidin conjugates as it may cause high background.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.